Com-COV 3 study focuses on assessing a third dose booster va

The Com-COV 3 study has been commissioned through the NIHR and backed by £2.8 million government funding, with support from both the Vaccine Taskforce and National Institute for Health and Care Research (NIHR).

Related Keywords

United Kingdom , Jakob Cramer , Stanleyc Erck , Matthew Snape , Andrew Ustianowski , Emily Henderson , University Of Oxford , Committee On Vaccination , Care Research Wales , Regulatory Agency , Coalition For Epidemic Preparedness Innovations , Pfizer , National Institute For Health , National Infection Specialty , National Immunisation Schedule Evaluation Consortium , Vaccination Programme , Care Research , Clinical Development , Vaccine Taskforce , National Institute , Epidemic Preparedness Innovations , Chief Investigator , Joint National Infection Specialty Lead , Chief Executive Officer , Joint Committee , Research , Vaccine , Adolescents , Bacteria , Covid 19 , Efficacy , Healthcare , Hospital , Immune Response , Meningitis , Meningitis Vaccine , Paediatrics , Pandemic , Protein , Public Health , Running , Cars , Social Care , Virus ,